A detailed history of Prudential PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Prudential PLC holds 5,488 shares of MRNA stock, worth $202,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,488
Previous 5,488 -0.0%
Holding current value
$202,232
Previous $651,000 43.78%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $386,811 - $523,058
-4,531 Reduced 45.22%
5,488 $584,000
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $695 - $1,044
10 Added 0.1%
10,019 $996,000
Q3 2023

Nov 09, 2023

SELL
$96.41 - $126.61 $117,138 - $153,831
-1,215 Reduced 10.83%
10,009 $1.03 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $7,347 - $9,952
-62 Reduced 0.55%
11,224 $1.36 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $3,120 - $4,531
23 Added 0.2%
11,286 $1.73 Million
Q4 2022

Feb 08, 2023

SELL
$118.38 - $210.04 $476,124 - $844,780
-4,022 Reduced 26.31%
11,263 $2.02 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $678,784 - $1.12 Million
5,749 Added 60.29%
15,285 $1.81 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $75,080 - $113,194
641 Added 7.21%
9,536 $1.36 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $721,580 - $1.34 Million
5,706 Added 178.93%
8,895 $1.53 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $720,139 - $1.18 Million
3,189 New
3,189 $810,000
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $1.89 Million - $3.41 Million
-14,515 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $1.58 Million - $2.7 Million
14,515 New
14,515 $1.9 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.